Navigation Links
Novavax Reports First Quarter 2008 Financial Results
Date:5/9/2008

uenza vaccine program is planned in

older adult subjects commencing in the fourth quarter of 2008. The

intent of this head-to-head trial is to evaluate the immunogenicity of

the seasonal influenza VLP vaccine candidate as compared with that of

an approved, marketed vaccine in the older adult population.

-- Continued to advance two additional new vaccine discovery programs, one

for Varicella Zoster (Shingles) and a second for an undisclosed disease

target with the goal of progressing both of these candidates through

proof of concept animal studies during the next two quarters.

-- Enhanced VLP technology capabilities by developing a new approach in

creating VLPs that expands our ability to apply VLPs to a broader

number of potential vaccine disease targets.

-- Announced the completion of construction for our GMP pilot plant in the

Company's Rockville, Maryland headquarters with a ribbon cutting

ceremony held on May 1, 2008. This facility will showcase the

capability of our ready to use and disposable production technology in

a relatively low cost environment.

-- Progressed the collaboration with GE Healthcare to develop and market a

pandemic influenza vaccine manufacturing solution for selected

international countries.

-- Completed the sale of assets related to Estrasorb in the United States,

Canada and Mexico to Graceway Pharmaceuticals, LLC ("Graceway") in

February 2008. As part of that sale, Novavax entered into a supply

agreement with Graceway which requires the Company to manufacture

additional units of Estrasorb, with final delivery expected in mid-

2008.

"We continue to make solid progress in our clinical development programs and currently are on track to achieve our plans for 2008," said Novavax Chief Executive Officer Dr. Rahul Singhvi. "By th
'/>"/>

SOURCE Novavax, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Novavax CEO to Present at BIO CEO & Investor Conference
2. Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
3. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
4. Novavax CEO to Present at the World Vaccine Congress 2008
5. Novavax Opens Its First U.S. Vaccine Plant
6. Novavax Announces Release Date of 2008 First Quarter Financial Results and Investor Conference Call
7. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
8. QMed, Inc. Reports July Medicare SNP Enrollments
9. Phlo Affiliate Reports Expanded Coverage to Oregon Border
10. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
11. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... , Jan. 22, 2015   GenoSpace , a precision medicine ... to enable the broad use of genomic, imaging and other ... appointment of Michelle Munson , CEO of Aspera, an ... Logo - http://photos.prnewswire.com/prnh/20150122/170713 "We ...
(Date:12/24/2014)... YORK , Dec. 24, 2014 PlasmaTech Biopharmaceuticals, Inc. ... critical areas, announced the closing of an underwritten public offering ... up to an aggregate 3,500,000 shares of common stock, at ... warrant.  The warrants have a per share exercise price of ...
(Date:12/24/2014)... 2014 GMO corn cases filed across the ... the process of being consolidated in a Kansas federal court ... AG MIR 162 Corn Litigation, MDL No. 2591 in the ... of the Syngenta GMO corn multidistrict litigation (MDL) has been ...
(Date:12/24/2014)... Island, New York (PRWEB) December 23, 2014 ... and the Long Island Affiliate of ITRA Global, the national ... slow but steady recovery. This is evidenced by the ... the strong stock market. Low energy costs have held ...
Breaking Biology Technology:GenoSpace Expands Board with Appointment of Michelle Munson 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3
... -- I continue to be encouraged by the numerous ... Midwest. Here are just a few: , ,& bull; The ... 2006. , ,& bull; The continued acquisition of Midwest ... recognize the value of Midwest products and technology, the flip ...
... in Memphis, Tenn., will install a wireless distribution ... organization's corporate office under a $6 million agreement with ... distribution system will provide wireless coverage throughout Baptist's six ... system, which will be installed in the next 12 ...
... a biophysical chemist at the University of Wisconsin-Madison, has ... the Biophysical Society, a 7,000-member U.S. organization that represents ... and biochemistry, Record hopes that the new honor will ... funding for his research. , ,A UW-Madison faculty member ...
Cached Biology Technology:Midwest biotech on a roll 2Midwest biotech on a roll 3Midwest biotech on a roll 4
(Date:1/22/2015)... 22, 2015 Research and Markets ( ... "Global Wearable Technologies Market and Applications, Opportunities, ... and Forecast 2014-2020" report to their offering. ... devices that can be worn on the user,s ...
(Date:12/24/2014)... , Dec. 23, 2014  Since its launch in December 2014, ... to eliminate the pain of trying to remember their usernames ... biometrics fused to their smartphones. To assist people who have ... the company that created 1U and focuses on redefining identity, ...
(Date:12/22/2014)... , Dec. 22, 2014  The 2014 Holiday Season ... as Acuity Market Intelligence reports that the long anticipated ... forecasts that intensifying demand for smart phones, tablets, and ... global market of 2.5 billion users with nearly 4.8 ...
Breaking Biology News(10 mins):Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 3First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2
... as well known for keeping us healthy as it is ... a new research report appearing in the March 2010 print ... scientists explain how they developed a genetically modified strain of ... scum, scientifically known as microcystin-LR (MC-LR), which makes water unsafe ...
... silkworm moths, butterflies and spiders, caddisfly larvae spin silk, but ... of Utah researchers have discovered why the fly,s silk is ... as an adhesive tape during surgery. "Silk from caddisfly ... may be useful some day as a medical bioadhesive ...
... of business for any fledgling plant embryo is to determine which ... researchers at the Salk Institute expose the turf wars between two ... polar axis with a root on one end and a shoot ... important decision for a plant, setting up the root/shoot axis, occurs ...
Cached Biology News:Glue, fly, glue 2Glue, fly, glue 3Glue, fly, glue 4Glue, fly, glue 5Root or shoot 2Root or shoot 3
... Engine Dyad instrument is the most advanced ... MJ's world-class thermal performance, the Dyad also ... well as point-and-click navigation via touch pad ... be easily and economically expanded to a ...
...
...
... instrument is the most advanced thermal cycler ... thermal performance, the Dyad also boasts graphical ... point-and-click navigation via touch pad or mouse. ... and economically expanded to a four-bay system ...
Biology Products: